Sonnet Biotherapeutics Stock Forecast - 4 Period Moving Average
| SONN Stock | USD 2.90 0.02 0.68% |
The 4 Period Moving Average forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 2.94 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 28.83. Sonnet Stock Forecast is based on your current time horizon. Although Sonnet Biotherapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sonnet Biotherapeutics' systematic risk associated with finding meaningful patterns of Sonnet Biotherapeutics fundamentals over time.
Sonnet |
Sonnet Biotherapeutics 4 Period Moving Average Price Forecast For the 23rd of November
Given 90 days horizon, the 4 Period Moving Average forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 2.94 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.43, and the sum of the absolute errors of 28.83.Please note that although there have been many attempts to predict Sonnet Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sonnet Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sonnet Biotherapeutics Stock Forecast Pattern
| Backtest Sonnet Biotherapeutics | Sonnet Biotherapeutics Price Prediction | Buy or Sell Advice |
Sonnet Biotherapeutics Forecasted Value
In the context of forecasting Sonnet Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sonnet Biotherapeutics' downside and upside margins for the forecasting period are 0.03 and 9.84, respectively. We have considered Sonnet Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Sonnet Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sonnet Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.744 |
| Bias | Arithmetic mean of the errors | 0.1346 |
| MAD | Mean absolute deviation | 0.4971 |
| MAPE | Mean absolute percentage error | 0.093 |
| SAE | Sum of the absolute errors | 28.8325 |
Predictive Modules for Sonnet Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sonnet Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Sonnet Biotherapeutics
For every potential investor in Sonnet, whether a beginner or expert, Sonnet Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sonnet Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sonnet. Basic forecasting techniques help filter out the noise by identifying Sonnet Biotherapeutics' price trends.Sonnet Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonnet Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Sonnet Biotherapeutics could also be used in its relative valuation, which is a method of valuing Sonnet Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sonnet Biotherapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sonnet Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sonnet Biotherapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sonnet Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Sonnet Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonnet Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Sonnet Biotherapeutics stock market strength indicators, traders can identify Sonnet Biotherapeutics Holdings entry and exit signals to maximize returns.
Sonnet Biotherapeutics Risk Indicators
The analysis of Sonnet Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sonnet Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sonnet stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.76 | |||
| Standard Deviation | 6.83 | |||
| Variance | 46.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock: Check out Historical Fundamental Analysis of Sonnet Biotherapeutics to cross-verify your projections. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.